Our compounded provider-guided Tirzepatide (GLP-1 + GIP) injectable therapy may be prescribed by a licensed provider to support metabolic health, appetite regulation, and overall wellness as part of a personalized care plan
GLP-1 & SGLT2 Inhibitor Combination Therapy Combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors represents an advanced treatment strategy for type 2 diabetes mellitus, utilising two distinct drug classes with complementary mechanisms of action
January 2025 The lawsuits against GLP-1 drug makers, like Novo Nordisk (Ozempic), are increasing
Finally the degree in which the adverse effects of GLP-agonists on the neonate can be ascribed to maternal malnutrition could be assessed in multiple animal models where the female gets pregnant during either the catabolic stage of GLP-1 agonist exposure or after reaching a stable body weight
Drinking alcohol may mask symptoms of low blood sugar or cause unpredictable blood sugar swings, making management more challenging
However, discontinuing these medicines can lead to significant metabolic changes, including deterioration in blood glucose control and weight regain